Axon Historical Balance Sheet

AXON Stock

USD 577.18 4.66 0.81%

Trend analysis of Axon Enterprise balance sheet accounts such as Short Long Term Debt Total of 757.8 M, Other Current Liabilities of 299.1 M or Total Current Liabilities of 1 B provides information on Axon Enterprise's total assets, liabilities, and equity, which is the actual value of Axon Enterprise to its prevalent stockholders. By breaking down trends over time using Axon Enterprise balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Axon Enterprise latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Axon Enterprise is a good buy for the upcoming year.

Axon Enterprise Inventory

278.58 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.

About Axon Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Axon Enterprise at a specified time, usually calculated after every quarter, six months, or one year. Axon Enterprise Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Axon Enterprise and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Axon currently owns. An asset can also be divided into two categories, current and non-current.

Axon Enterprise Balance Sheet Chart

At this time, Axon Enterprise's Current Deferred Revenue is very stable compared to the past year. As of the 25th of March 2025, Net Debt is likely to grow to about 280.2 M, while Common Stock Total Equity is likely to drop 746.90.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Capital Surpluse

Add Fundamental

Total Assets

Total assets refers to the total amount of Axon Enterprise assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Axon Enterprise books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Axon Enterprise balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Axon Enterprise are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Axon Enterprise's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Axon Enterprise current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.At this time, Axon Enterprise's Current Deferred Revenue is very stable compared to the past year. As of the 25th of March 2025, Net Debt is likely to grow to about 280.2 M, while Common Stock Total Equity is likely to drop 746.90.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	711.1M	710.7M	721.7M	757.8M
Total Assets	2.9B	3.4B	4.5B	4.7B

Short Long Term Debt Total Total Assets

Axon Enterprise balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Treasury Stock	Short Term Debt
Total Assets		0.94	0.77	1.0	0.99	0.99	1.0	0.65	0.94	0.96	0.89	0.98	0.76	0.83	0.99	0.27	0.75	0.97	0.98	0.88	0.98	0.99	0.98	0.98	-0.42	0.0
Short Long Term Debt Total	0.94		0.73	0.93	0.89	0.92	0.93	0.82	0.86	0.95	0.82	0.9	0.6	0.84	0.9	0.19	0.7	0.99	0.96	0.78	0.87	0.97	0.91	0.93	-0.31	-0.27
Other Current Liab	0.77	0.73		0.76	0.76	0.81	0.77	0.49	0.54	0.75	0.71	0.7	0.71	0.76	0.8	0.26	0.68	0.76	0.78	0.5	0.83	0.76	0.68	0.8	-0.42	0.29
Total Current Liabilities	1.0	0.93	0.76		0.99	0.99	1.0	0.63	0.94	0.97	0.9	0.97	0.75	0.82	0.99	0.27	0.75	0.97	0.99	0.88	0.97	0.99	0.98	0.98	-0.43	0.02
Total Stockholder Equity	0.99	0.89	0.76	0.99		0.98	0.99	0.57	0.94	0.94	0.88	0.97	0.79	0.8	0.99	0.29	0.74	0.94	0.96	0.9	0.99	0.97	0.98	0.97	-0.44	0.09
Property Plant And Equipment Net	0.99	0.92	0.81	0.99	0.98		0.99	0.6	0.89	0.97	0.91	0.94	0.76	0.87	0.99	0.29	0.79	0.96	0.99	0.82	0.98	0.98	0.97	0.99	-0.44	0.07
Current Deferred Revenue	1.0	0.93	0.77	1.0	0.99	0.99		0.61	0.93	0.97	0.91	0.97	0.76	0.83	1.0	0.28	0.75	0.97	0.99	0.87	0.98	0.99	0.98	0.98	-0.45	0.04
Net Debt	0.65	0.82	0.49	0.63	0.57	0.6	0.61		0.63	0.62	0.35	0.68	0.13	0.47	0.57	-0.06	0.37	0.77	0.67	0.61	0.53	0.71	0.63	0.6	0.06	-0.64
Retained Earnings	0.94	0.86	0.54	0.94	0.94	0.89	0.93	0.63		0.85	0.78	0.97	0.62	0.63	0.91	0.27	0.63	0.9	0.89	0.97	0.88	0.92	0.96	0.88	-0.37	-0.13
Accounts Payable	0.96	0.95	0.75	0.97	0.94	0.97	0.97	0.62	0.85		0.93	0.89	0.76	0.93	0.95	0.31	0.79	0.97	0.98	0.75	0.94	0.97	0.94	0.99	-0.47	-0.01
Cash	0.89	0.82	0.71	0.9	0.88	0.91	0.91	0.35	0.78	0.93		0.8	0.86	0.9	0.9	0.36	0.77	0.86	0.9	0.67	0.9	0.89	0.86	0.94	-0.55	0.2
Non Current Assets Total	0.98	0.9	0.7	0.97	0.97	0.94	0.97	0.68	0.97	0.89	0.8		0.66	0.69	0.96	0.22	0.67	0.94	0.93	0.96	0.94	0.96	0.97	0.92	-0.33	-0.07
Long Term Debt	0.76	0.6	0.71	0.75	0.79	0.76	0.76	0.13	0.62	0.76	0.86	0.66		0.81	0.79	0.37	0.69	0.67	0.72	0.53	0.84	0.71	0.69	0.81	-0.61	0.49
Cash And Short Term Investments	0.83	0.84	0.76	0.82	0.8	0.87	0.83	0.47	0.63	0.93	0.9	0.69	0.81		0.82	0.35	0.78	0.84	0.88	0.48	0.84	0.84	0.77	0.91	-0.54	0.11
Net Receivables	0.99	0.9	0.8	0.99	0.99	0.99	1.0	0.57	0.91	0.95	0.9	0.96	0.79	0.82		0.28	0.75	0.95	0.97	0.87	0.99	0.98	0.97	0.98	-0.44	0.11
Common Stock Total Equity	0.27	0.19	0.26	0.27	0.29	0.29	0.28	-0.06	0.27	0.31	0.36	0.22	0.37	0.35	0.28		0.71	0.23	0.29	0.15	0.29	0.25	0.24	0.31	-0.86	0.28
Common Stock Shares Outstanding	0.75	0.7	0.68	0.75	0.74	0.79	0.75	0.37	0.63	0.79	0.77	0.67	0.69	0.78	0.75	0.71		0.73	0.77	0.53	0.76	0.74	0.71	0.79	-0.66	0.18
Non Current Liabilities Total	0.97	0.99	0.76	0.97	0.94	0.96	0.97	0.77	0.9	0.97	0.86	0.94	0.67	0.84	0.95	0.23	0.73		0.98	0.83	0.92	0.99	0.95	0.96	-0.36	-0.17
Inventory	0.98	0.96	0.78	0.99	0.96	0.99	0.99	0.67	0.89	0.98	0.9	0.93	0.72	0.88	0.97	0.29	0.77	0.98		0.81	0.96	0.99	0.97	0.99	-0.45	-0.03
Other Current Assets	0.88	0.78	0.5	0.88	0.9	0.82	0.87	0.61	0.97	0.75	0.67	0.96	0.53	0.48	0.87	0.15	0.53	0.83	0.81		0.83	0.86	0.91	0.79	-0.22	-0.13
Other Stockholder Equity	0.98	0.87	0.83	0.97	0.99	0.98	0.98	0.53	0.88	0.94	0.9	0.94	0.84	0.84	0.99	0.29	0.76	0.92	0.96	0.83		0.95	0.95	0.98	-0.46	0.19
Total Liab	0.99	0.97	0.76	0.99	0.97	0.98	0.99	0.71	0.92	0.97	0.89	0.96	0.71	0.84	0.98	0.25	0.74	0.99	0.99	0.86	0.95		0.97	0.98	-0.39	-0.09
Property Plant And Equipment Gross	0.98	0.91	0.68	0.98	0.98	0.97	0.98	0.63	0.96	0.94	0.86	0.97	0.69	0.77	0.97	0.24	0.71	0.95	0.97	0.91	0.95	0.97		0.96	-0.36	-0.04
Total Current Assets	0.98	0.93	0.8	0.98	0.97	0.99	0.98	0.6	0.88	0.99	0.94	0.92	0.81	0.91	0.98	0.31	0.79	0.96	0.99	0.79	0.98	0.98	0.96		-0.48	0.06
Treasury Stock	-0.42	-0.31	-0.42	-0.43	-0.44	-0.44	-0.45	0.06	-0.37	-0.47	-0.55	-0.33	-0.61	-0.54	-0.44	-0.86	-0.66	-0.36	-0.45	-0.22	-0.46	-0.39	-0.36	-0.48		-0.47
Short Term Debt	0.0	-0.27	0.29	0.02	0.09	0.07	0.04	-0.64	-0.13	-0.01	0.2	-0.07	0.49	0.11	0.11	0.28	0.18	-0.17	-0.03	-0.13	0.19	-0.09	-0.04	0.06	-0.47

Click cells to compare fundamentals

Axon Enterprise Account Relationship Matchups

Axon Enterprise balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.4B	1.7B	2.9B	3.4B	4.5B	4.7B
Short Long Term Debt Total	24.4M	27.0M	711.1M	710.7M	721.7M	757.8M
Other Current Liab	228.3M	382.6M	522.8M	214.2M	284.8M	299.1M
Total Current Liabilities	256.3M	418.5M	602.6M	800.0M	997.6M	1.0B
Total Stockholder Equity	976.3M	1.0B	1.3B	1.6B	2.3B	2.4B
Property Plant And Equipment Net	105.5M	138.5M	169.8M	236.7M	247.3M	259.7M
Current Deferred Revenue	166.9M	276.1M	380.4M	491.7M	613.0M	643.6M
Net Debt	(131.1M)	(329.4M)	357.4M	112.1M	266.8M	280.2M
Retained Earnings	169.9M	109.9M	257.0M	431.2M	812.0M	852.6M
Accounts Payable	24.1M	32.2M	59.9M	88.3M	72.0M	75.6M
Cash	155.4M	356.3M	353.7M	598.5M	454.8M	477.6M
Non Current Assets Total	399.1M	578.7M	1.0B	1.0B	2.2B	2.3B
Cash And Short Term Investments	562.0M	443.0M	974.7M	1.3B	653.1M	685.8M
Net Receivables	293.1M	501.2M	555.1M	693.5M	915.5M	961.3M
Common Stock Shares Outstanding	61.8M	66.2M	72.5M	75.5M	78.6M	63.7M
Liabilities And Stockholders Equity	1.4B	1.7B	2.9B	3.4B	4.5B	4.7B
Non Current Liabilities Total	148.4M	221.8M	980.8M	1.0B	1.1B	1.2B
Inventory	90.0M	108.7M	202.5M	269.9M	265.3M	278.6M
Other Current Assets	36.9M	56.5M	73.0M	112.8M	463.6M	486.7M
Other Stockholder Equity	806.2M	939.3M	1.0B	1.2B	1.5B	1.6B
Total Liab	404.8M	640.4M	1.6B	1.8B	2.1B	2.3B
Property Plant And Equipment Gross	127.8M	138.5M	169.8M	341.9M	427.9M	449.3M
Total Current Assets	982.0M	1.1B	1.8B	2.4B	2.3B	2.4B
Accumulated Other Comprehensive Income	141K	(1.3M)	(7.2M)	(10.7M)	(18.2M)	(17.3M)
Short Term Debt	59.8M	103.7M	6.4M	5.8M	6.7M	6.3M
Property Plant Equipment	43.8M	105.5M	138.5M	208.2M	239.4M	251.4M
Non Currrent Assets Other	122.5M	139.3M	210.0M	264.8M	361.0M	379.0M
Intangible Assets	9.4M	15.5M	12.2M	19.5M	175.2M	183.9M
Other Assets	258.9M	266.4M	328.5M	1.0	1.15	1.09
Other Liab	99.8M	148.4M	221.8M	269.6M	310.1M	325.6M
Short Term Investments	406.5M	86.7M	621.0M	722.0M	198.3M	146.2M
Net Tangible Assets	505.7M	941.6M	988.8M	1.2B	1.4B	1.5B
Good Will	25.2M	43.6M	45.0M	57.9M	756.8M	794.7M
Retained Earnings Total Equity	171.4M	172.3M	169.9M	109.9M	126.4M	117.9M
Capital Surpluse	453.4M	528.3M	962.2M	1.1B	1.3B	1.3B
Deferred Long Term Liab	8.1M	5.4M	6.5M	96.3M	110.7M	116.2M

Pair Trading with Axon Enterprise

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axon Enterprise position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axon Enterprise will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axon Stock

0.64

Boeing

Pair Corr

Moving against Axon Stock

0.73	RGR	Sturm Ruger	Pair Corr
0.48	ERJ	Embraer SA ADR	Pair Corr
0.44	HEI	Heico	Pair Corr
0.41	ESLT	Elbit Systems	Pair Corr
0.31	EH	Ehang Holdings	Pair Corr

The ability to find closely correlated positions to Axon Enterprise could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axon Enterprise when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axon Enterprise - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axon Enterprise to buy it.

The correlation of Axon Enterprise is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axon Enterprise moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axon Enterprise moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axon Enterprise can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axon Enterprise offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axon Enterprise's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axon Enterprise Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axon Enterprise Stock:

How To Invest In Axon

Details

Is Axon Stock a good investment?

Details

What is Axon Enterprise's Net Worth?

Details

Largest Aerospace & Defense Companies

View

Largest Industrials Companies

View

To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Aerospace & Defense space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axon Enterprise. If investors know Axon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axon Enterprise listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.225

Earnings Share

4.81

Revenue Per Share

27.493

Quarterly Revenue Growth

0.336

Return On Assets

0.0122

The market value of Axon Enterprise is measured differently than its book value, which is the value of Axon that is recorded on the company's balance sheet. Investors also form their own opinion of Axon Enterprise's value that differs from its market value or its book value, called intrinsic value, which is Axon Enterprise's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axon Enterprise's market value can be influenced by many factors that don't directly affect Axon Enterprise's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axon Enterprise's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axon Enterprise is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axon Enterprise's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axon Historical Balance Sheet

Axon Enterprise Inventory

278.58 Million

About Axon Balance Sheet Analysis

Axon Enterprise Balance Sheet Chart

Total Assets

Total Current Liabilities

Axon Enterprise balance sheet Correlations

Axon Enterprise Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axon Enterprise balance sheet Accounts

Pair Trading with Axon Enterprise

Moving together with Axon Stock

Moving against Axon Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Current Deferred Revenue	+ 1.0	Total Assets
Current Deferred Revenue	+ 1.0	Total Current Liabilities
Net Receivables	+ 1.0	Current Deferred Revenue
Total Stockholder Equity	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets

Treasury Stock	- 0.86	Common Stock Total Equity
Treasury Stock	- 0.66	Common Stock Shares Outstanding
Short Term Debt	- 0.64	Net Debt
Treasury Stock	- 0.61	Long Term Debt
Treasury Stock	- 0.55	Cash
Treasury Stock	- 0.54	Cash And Short Term Investments